A股異動丨永福股份大漲超10% 聯合體預中標2.78億元重大EPC工程總承包項目
格隆匯12月2日丨永福股份大漲超10%,報50.45元,總市值93億元。永福股份公吿,沅江市豐昇農林開發有限公司於2022年11月30日在中國招標投標公共服務平台發佈了《湖南沅江市泗湖山40MW風電場EPC總承包工程項目中標候選人公示》,公司與全資子公司福州新創機電設備有限公司組成的聯合體為該項目第一中標候選人,預中標金額為2.78億元,約佔公司2021年度經審計總承包工程業務營業收入12.62億元人民幣的22.02%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.